Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E, Ruano Y, García-Martín RM, Lora D, Cifdaloz M, Acquadro F, Ballestín C, Ortiz-Romero PL, Soengas MS, Rodríguez-Peralto JL. Riveiro-Falkenbach E, et al. Among authors: lora d. Pigment Cell Melanoma Res. 2017 Mar;30(2):194-202. doi: 10.1111/pcmr.12563. Epub 2017 Mar 7. Pigment Cell Melanoma Res. 2017. PMID: 27893188
Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
Pérez-Regadera J, Sánchez-Muñoz A, De-la-Cruz J, Ballestín C, Lora D, García-Martín R, Sotoca A, Pérez-Ruiz E, Lanzós E. Pérez-Regadera J, et al. Among authors: lora d. Am J Clin Oncol. 2011 Aug;34(4):395-400. doi: 10.1097/COC.0b013e3181e84634. Am J Clin Oncol. 2011. PMID: 20859196
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, Alonso-Curbelo D, Suarez J, Osterloh L, Graña O, Mulero F, Megías D, Cañamero M, Martínez-Torrecuadrada JL, Mondal C, Di Martino J, Lora D, Martinez-Corral I, Bravo-Cordero JJ, Muñoz J, Puig S, Ortiz-Romero P, Rodriguez-Peralto JL, Ortega S, Soengas MS. Olmeda D, et al. Among authors: lora d. Nature. 2017 Jun 28;546(7660):676-680. doi: 10.1038/nature22977. Nature. 2017. PMID: 28658220 Free PMC article.
Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.
Maroñas-Jiménez L, Estrach T, Gallardo F, Pérez A, Andrés Borja H, Servitje O, Pérez Gala S, Linares Barrio M, Jiménez Gallo D, Sanz-Bueno J, Lora D, Monsálvez V, Ortiz-Romero PL. Maroñas-Jiménez L, et al. Among authors: lora d. Br J Dermatol. 2018 Apr;178(4):e273-e274. doi: 10.1111/bjd.16128. Epub 2018 Feb 22. Br J Dermatol. 2018. PMID: 29150837 No abstract available.
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial.
Ortiz-Romero PL, Maroñas Jiménez L, Muniesa C, Estrach T, Servitje O, Fernández-de-Misa R, Gallardo F, Sanmartín O, Riveiro-Falkenbach E, García-Díaz N, Vega R, Lora D, Postigo C, Jiménez B, Sánchez-Beato M, Pedro Vaqué J, Rodríguez Peralto JL, de la Cámara AG, de la Cruz J, Piris Pinilla MÁ. Ortiz-Romero PL, et al. Among authors: lora d. Lancet Haematol. 2022 Jun;9(6):e425-e433. doi: 10.1016/S2352-3026(22)00107-7. Lancet Haematol. 2022. PMID: 35654076 Clinical Trial.
Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB2 harmonization project comparing three NGS panels.
Ramos-Paradas J, Hernández-Prieto S, Lora D, Sanchez E, Rosado A, Caniego-Casas T, Carrizo N, Enguita AB, Muñoz-Jimenez MT, Rodriguez B, Perez-Gonzalez U, Gómez-Sánchez D, Ferrer I, Ponce Aix S, Nuñez Buiza Á, Garrido P, Palacios J, Lopez-Rios F, Garrido-Martin EM, Paz-Ares L. Ramos-Paradas J, et al. Among authors: lora d. J Immunother Cancer. 2021 May;9(5):e001904. doi: 10.1136/jitc-2020-001904. J Immunother Cancer. 2021. PMID: 33963008 Free PMC article.
Metrics of progression and prognosis in untreated adults with thymidine kinase 2 deficiency: An observational study.
Domínguez-González C, Hernández-Voth A, de Fuenmayor-Fernández de la Hoz CP, Guerrero LB, Morís G, García-García J, Muelas N, León Hernández JC, Rabasa M, Lora D, Blázquez A, Arenas J, Martin MÁ. Domínguez-González C, et al. Among authors: lora d. Neuromuscul Disord. 2022 Sep;32(9):728-735. doi: 10.1016/j.nmd.2022.07.399. Epub 2022 Jul 16. Neuromuscul Disord. 2022. PMID: 35907766 Free article.
90 results